NEOMYCIN-POLYMYXIN-HC EAR SUSP

What it is

NEOMYCIN-POLYMYXIN-HC EAR SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “neomycin sulfate, polymyxin b sulfate and hydrocortisone” and “neomycin and polymyxin b sulfates and hydrocortisone otic”, as its NDCs’ listings variously write the nonproprietary name, under the trade names “Neomycin and Polymyxin B Sulfates and Hydrocortisone” and “Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension”.

FDA gives its dosage form as “suspension/ drops” and “suspension” and its route as auricular (otic).

Its labelers, the companies named on the label, are Bausch & Lomb Incorporated, Sandoz Inc. and Rising Pharma Holdings, Inc.

FDA lists it under 3 Established Pharmacologic Classes: Aminoglycoside Antibacterial, Corticosteroid and Polymyxin-class Antibacterial.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $38.33 for 10 mL (10 × $3.83312 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · NADAC explanation codes

All 3 NDCs

• 24208-0635-62 · Bausch & Lomb Incorporated · $3.83312 per ML · eff. 2026-09-23 filed
• 61314-0645-11 · Sandoz Inc. · $3.83312 per ML · eff. 2026-09-23 filed
• 64980-0448-01 · Rising Pharma Holdings, Inc. · $3.83312 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares an FDA nonproprietary name with NEOMYCIN-POLYMYXIN-HC EAR SUSP.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $3.83312 per ML filed.

Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 8 have a higher middle NADAC price and 7 a lower one. The one in the middle is TOBRAMYCIN-DEXAMETH OPHTH SUSP, at $4.1784 per ML filed (eff. 2026-09-23).

Of the 106 other products in FDA’s Corticosteroid class priced per ML, 44 have a higher middle NADAC price and 62 a lower one. The one in the middle is FLUNISOLIDE 0.025% SPRAY, at $1.98777 per ML filed (eff. 2026-09-23).

Of the 5 other products in FDA’s Polymyxin-class Antibacterial class priced per ML, 3 have a higher middle NADAC price and 2 a lower one. The one in the middle is NEOMYC-POLYM-GRAMICID EYE DROP, at $4.58557 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 10 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 10 mL; your package may hold a different amount.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.